Advancement of antiangiogenic and vascular disrupting agents combined with radiation.
Citrin
Deborah
D
Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA.
Camphausen
Kevin
K
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods*
D020533:Angiogenesis Inhibitors